Showing results (2071-2080 of 2,573) with videos related to

Sort By:
Pageof 258
Drug Testing and Analysis|March 23, 2019
Anti-doping analytes in serum: A comparison of SST and SST-II Advance blood collection tubesGeoffrey D Miller, Holly D Cox, Vinod Nair, et al.
Drug Testing and Analysis|March 27, 2019
Zolpidem and zolpidem phenyl-4-carboxylic acid pharmacokinetics in oral fluid after a single doseXueyi Feng, Hang Chen, Ping Xiang, et al.
Drug Testing and Analysis|April 6, 2019
Alterations in phospholipid profiles of erythrocytes deep-frozen without cryoprotectantsYoeseph Cho, Ji-Hye Woo, Oh-Seung Kwon, et al.
Drug Testing and Analysis|March 7, 2014
The rise of new psychoactive substance use in AustraliaLucy Burns, Amanda Roxburgh, Allison Matthews, et al.
Drug Testing and Analysis|April 14, 2017
Doping control study of AICAR in post-race urine and plasma samples from horsesJenny K Y Wong, Wai Him Kwok, George H M Chan, et al.
Drug Testing and Analysis|August 28, 2019
Evaluation of impurities and dissolution profiles of illegal antimicrobial drugs encountered in BelgiumYaxin Tie, Kevin van Loock, Eric Deconinck, et al.
Drug Testing and Analysis|August 14, 2019
A systematic investigation of forensic hair decontamination procedures and their limitationsDylan Mantinieks, Paul Wright, Matthew Di Rago, et al.
Drug Testing and Analysis|August 14, 2019
Detectability of various cannabinoids in plasma samples of cannabis users: Indicators of recent cannabis use?Michael Kraemer, Burkhard Madea, Cornelius Hess
Drug Testing and Analysis|August 29, 2019
5F-MDMB-PICA metabolite identification and cannabinoid receptor activityMichael T Truver, Shimpei Watanabe, Anna Åstrand, et al.
Drug Testing and Analysis|September 4, 2019
Identification of a thermal degradation product of CUMYL-PEGACLONE and its detection in biological samplesChristine Nash, Linda Glowacki, Dimitri Gerostamoulos, et al.
Pageof 258